Acalabrutinib CYP3A‐mediated drug–drug interactions: Clinical evaluations and physiologically based pharmacokinetic modelling to inform dose adjustment strategy

基于生理学的药代动力学模型 药理学 氟康唑 药代动力学 CYP3A型 药品 化学 伊曲康唑 不利影响 治疗药物监测 医学 内科学 细胞色素P450 抗真菌 皮肤病科 新陈代谢
作者
Buyun Chen,Diansong Zhou,Hua Wei,Marmor Yotvat,Li Zhou,Jean Cheung,Nicole Sarvaria,R. Lai,Shringi Sharma,Karthick Vishwanathan,Joseph A. Ware
出处
期刊:British Journal of Clinical Pharmacology [Wiley]
卷期号:88 (8): 3716-3729 被引量:8
标识
DOI:10.1111/bcp.15278
摘要

Clinical drug interaction studies with itraconazole and rifampicin have demonstrated that acalabrutinib is a sensitive substrate of CYP3A. A physiologically based pharmacokinetic (PBPK) model was developed based on the data of these studies. One of the active CYP3A metabolites, ACP-5862, was identified but never studied in a drug interaction scenario. This study aims to evaluate both parent and metabolite exposure change with coadministration of moderate CYP3A inhibitors and its impact on safety and efficacy.In an open label, randomized, 2-period study, we investigated the effect of coadministration of fluconazole or isavuconazole on the pharmacokinetics of acalabrutinib. Bruton tyrosine kinase receptor occupancy and safety were compared between different treatments. Experimental data were compared to PBPK simulation results.Least square means of acalabrutinib maximum plasma concentration and area under the curve increased 1.37 (1.14-1.64) and 1.60 (1.45-1.77)-fold in the presence of isavuconazole and 1.48 (1.10-1.98) and 2.16 (1.94-2.40)-fold in the presence of fluconazole, respectively. For ACP-5862, these values are 0.72 (0.63-0.82) and 0.91 (0.86-0.97) fold for isavuconazole and 0.65 (0.49-0.87) and 0.95 (0.91-0.99) fold for fluconazole coadministration. The PBPK model was able to recover acalabrutinib and ACP-5862 PK profiles in the study. Bruton tyrosine kinase receptor occupancy change was minimal in the presence of isavuconazole. There were no deaths, serious adverse events (AEs), or subject discontinuation due to AEs in this study. Only mild (Grade 1) AEs were reported during the study, by 17% of the study population.Our results demonstrate the impact of fluconazole and isavuconazole on the pharmacokinetics of acalabrutinib and ACP-5862, and suggest that no dose adjustment is needed for concomitant administration with moderate CYP3A inhibitors. the current PBPK model can be used to propose dose adjustment for drug interactions via CYP3A.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
浩浩完成签到 ,获得积分10
1秒前
5秒前
8秒前
Yunus发布了新的文献求助10
9秒前
11秒前
dldldl完成签到,获得积分10
11秒前
xdmhv完成签到 ,获得积分10
13秒前
wwj1009完成签到 ,获得积分10
14秒前
秋迎夏发布了新的文献求助10
14秒前
yar应助aiyawy采纳,获得10
15秒前
华仔应助果粒多采纳,获得10
17秒前
Yunus完成签到,获得积分10
19秒前
jerry完成签到 ,获得积分10
20秒前
萌新完成签到 ,获得积分10
23秒前
27秒前
asdf完成签到,获得积分10
28秒前
31秒前
31秒前
资山雁完成签到 ,获得积分10
33秒前
果粒多发布了新的文献求助10
34秒前
为你钟情完成签到 ,获得积分10
36秒前
懒癌晚期完成签到,获得积分10
38秒前
张csc完成签到 ,获得积分10
41秒前
一枝完成签到 ,获得积分10
41秒前
梦XING完成签到 ,获得积分10
42秒前
舒适映寒完成签到,获得积分10
43秒前
幽默梦之完成签到 ,获得积分10
43秒前
欢喜的凡之完成签到 ,获得积分10
47秒前
碎冰蓝完成签到,获得积分10
51秒前
怕孤独的香菇完成签到 ,获得积分10
53秒前
hcdb完成签到,获得积分10
53秒前
yk完成签到 ,获得积分10
54秒前
我爱康康文献完成签到 ,获得积分10
55秒前
55秒前
叶远望完成签到 ,获得积分10
56秒前
Jeffery426完成签到,获得积分10
1分钟前
貔貅完成签到,获得积分10
1分钟前
1分钟前
太叔夜南完成签到,获得积分10
1分钟前
小李新人完成签到 ,获得积分10
1分钟前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Immigrant Incorporation in East Asian Democracies 600
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3968559
求助须知:如何正确求助?哪些是违规求助? 3513391
关于积分的说明 11167370
捐赠科研通 3248808
什么是DOI,文献DOI怎么找? 1794465
邀请新用户注册赠送积分活动 875116
科研通“疑难数据库(出版商)”最低求助积分说明 804664